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Abstract
There are only two three-piece inflatable penile prostheses (IPP) available to patients in the American
market: the AMS (American Medical Systems) 700TM series (Boston Scientific, Massachusetts) and the
Coloplast Titan® series (Coloplast, Minnesota), and data comparing the two are scant. The aim of our study
was to summarize the current scientific evidence comparing the two.
A systematic literature review was conducted on PubMed. A 10-year filter was placed to include only studies
published after Coloplast launched the Titan Touch® release pump. Eligibility criteria included articles
discussing specifically the AMS 700TM and Coloplast Titan® models. Further searches for studies on
patient/partner satisfaction were conducted. Abstracts were reviewed to include studies focusing specifically
on the models we are studying and studies on patient satisfaction using the Erectile Dysfunction Inventory
of Treatment Satisfaction (EDITS) questionnaire.
The Coloplast device demonstrated slightly greater resistance to the stimulated forces of penetration and
gravity. Coloplast implants coated with vancomycin/gentamicin had the highest infection rate followed by
the AMS penile prosthesis and the rifampin/gentamicin coating had the lowest infection rate. Prosthesis
durability and survival were similar between both brands. Overall satisfaction was high but comparisons are
inconsistent.
The literature is inconclusive about which device is superior. We suggest randomized, multicenter,
prospective studies to help further elucidate the highlights of each product.
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Erectile dysfunction (ED) is a recurrent or consistent inability to acquire or sustain an erection of sufficient
rigidity and duration for sexual intercourse [1]. ED has been estimated to affect approximately 5%-20% of
men. Differences in the definitions of ED, as well as methodological differences, may explain the variety in
reported prevalence rates [2]. The Multinational Men’s Attitudes to Life Events and Sexuality study
identified the overall prevalence of ED to be 16% and found the prevalence to be 20% in the United States.
The prevalence also increased with age and other comorbid medical conditions such as cardiovascular
disease, hypertension, dyslipidemia, and depression. Of the men in the study, 58% had actively sought
medical attention for ED and only 16% were currently being treated with oral phosphodiesterase-5 inhibitor
(PDE-5) therapy [3].

source are credited.

As per evidence-based medicine, treatment for ED involves identifying the underlying etiology (including
drugs such as antidepressants and antihypertensive medications), identifying and treating cardiovascular
risk factors, and then initiating medical therapy with the first-line agents, PDE-5 inhibitors. If PDE-5
inhibitors are contraindicated or ineffective, vacuum devices, penile self-injectable drugs, and intraurethral
alprostadil are second-line therapy [1]. The surgical implantation of a penile prosthesis is indicated for men
who cannot use or have not responded to first- and second-line therapies and inflatable penile prostheses
(IPP) account for the majority of these implants [4]. However, the American Urological Association's clinical
guidelines now suggest that with proper counseling and shared decision-making, men can choose what their
initial therapy will be.
Currently, the only two three-piece IPPs manufactured in the United States are the AMS 700 TM series
prostheses (Boston Scientific, Massachusetts) and the Coloplast Titan® prostheses (Coloplast, Minnesota)
[5]. There are three variations in the AMS 700 TM line: the AMS 700 TM LGX, the AMS 700 TM CX, and the AMS
700TM CXR. Both the AMS 700 TM series and the Coloplast Titan® are three-component prostheses that
consist of two cylinders implanted into the corpora cavernosa, a pump placed in the scrotum, and a
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reservoir filled with saline placed in the space of Retzius or the high submuscular space. The AMS devices are
available with an outer layer of InhibizoneTM made of rifampin and minocycline to prevent infection. These
devices also have the Momentary Squeeze PumpTM, which allows users to press the button once and then
squeeze the cylinders (instead of having to do so simultaneously), making deflation easier, and it also has a
lockout valve that prevents auto-inflation. Coloplast has a hydrophilic coating that can absorb the
antibiotics into which it is immersed and a Titan® Touch release pump that requires only a compression of
the release pump to allow for complete cylinder deflation [6].
Given the difference in device design, we aimed to review the current scientific literature comparing these
two IPPs, which includes a biomechanical comparison, infection rates, the use of IPPs in Peyronie’s disease
(PD), and patient and partner satisfaction.

Review
Protocol
This is a systematic review of the literature concerning the comparison of the Coloplast Titan® and the AMS
700TM, as well as patient and partner satisfaction with each IPP. The methods and reporting follow the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [7].
Eligibility Criteria
The inclusion criterion for the first search was articles published in the last 10 years. This 10-year filter was
placed to include only studies published after Coloplast launched the Titan® Touch release pump for easier
deflation in 2008 [8]. Additional eligibility criteria included articles discussing specifically the AMS 700 TM
and Coloplast Titan® models. For the second and third searches, studies of IPP use for ED were eligible and
those studying IPPs implanted for PD were excluded. Additionally, abstracts were reviewed to include
studies focusing specifically on the models we are studying and studies on patient satisfaction using the
Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire.
Information Sources
Table 1 presents the keywords used and the results of the literature search. PubMed was searched using the
term “penile prosthesis AND comparison.” This yielded 37 articles. After reviewing abstracts for inclusion
criteria, six articles were included. The search term “Coloplast Titan® AND satisfaction” yielded 16 articles,
out of which two were included. A similar search using “AMS 700TM AND satisfaction” yielded 20 articles,
out of which two were included. Figure 1 presents the PRISMA diagram for our review. Table 2 presents a
summary of the study designs and characteristics.

Search Term

Number of Articles

Number Included

Penile prosthesis AND comparison

37

6 (Otero, Al Ansari, Morgado, Chung, Wallen, Dhabuwala)

Coloplast Titan AND satisfaction

16

2 (Lindeborg, Garrido)

AMS 700 AND satisfaction

20

2 (Negro, Vitarelli)

TABLE 1: Keywords and results of the literature search
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FIGURE 1: PRISMA diagram
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses

Author

Study Setting

Study Design

Sample
Size

Specific IPP Studied

Al Ansari et al. [9]

Qatar, 2013

Cross-sectional study

100

Coloplast Titan and AMS
700

Wallen et al. [10]

Florida, 2018

Biomechanical evaluation

-

Coloplast Titan and AMS
700

Dhabuwala et al.
[11]

Michigan,
2011

Review

339

Coloplast Titan and AMS
700

Chung et al. [12]

Canada, 2013

Review with cross-sectional survey

138

Coloplast Titan and AMS
700

Lindeborg et al. [13]

Denmark,
2014

Prospective cohort study with survey

26

Coloplast Titan

Garrido et al. [14]

Spain, 2015

Review with cross-sectional survey

100

Coloplast Titan

Negro et al. [15]

Italy, 2016

Prospective cohort study

36

AMS 700

Vitarelli et al. [16]

Italy, 2013

Review with cross-sectional survey

80

AMS 700

Otero et al. [17]

Spain, 2017

Retrospective non-randomized intervention
study

248

Coloplast Titan and AMS
700

Morgado et al. [18]

Portugal, 2018

Cross-sectional survey

55

Coloplast Titan and AMS
700

TABLE 2: Summary of study designs and characteristics

Study Selection
Results from the search were saved in a Microsoft Excel (Microsoft Corporation, Redmond, WA), spreadsheet,
and duplicates were removed. Two reviewers (EA and VW) independently reviewed titles and abstracts.
Disagreements were solved by consensus between them.
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Data Collection and Synthesis of Results
Data were collected in an Excel sheet and information included study setting, study design, sample size, and
specific IPP studied. The key results from selected studies were summarized in text.
Ethical Statement
This is a systematic review and meta‐analysis of published and open information. No human subjects were
involved in this project. This study was therefore classified as non-human subject research and no IRB
approval was necessary.

Literature review
Comparison of Biomechanics
A study by Al Ansari et al. aimed to look at the effects of axial rigidity on patient satisfaction rates in
different types of penile prosthetics. One-hundred patients were surveyed for satisfaction after penile
prosthesis implant surgery and the digital inflection rigometer (DIR) was used to assess axial rigidity.
Partners of patients were also surveyed for satisfaction after implantation. The study assessed various types
of IPPs, including Coloplast Titan® and AMS 700TM CX. Specifically, more patients received AMS 700 TM CX
(N=42) versus Coloplast Titan® (N=13) and Coloplast Titan OTR® (N=15). Mean DIR for the AMS 700TM CX
was 985 and for the Coloplast Titan® and Coloplast Titan OTR®, it was 1068 and 953, respectively. The
dissatisfaction rate of AMS 700TM CX was lower than both Titan® with a percentage of 2.4% versus 7.7% and
6.6%. Therefore, even with the slightly increased axial rigidity in Titan®, 700TM CX showed a lower
dissatisfaction rate [9].
Wallen et al. looked at the biomechanical properties of three different penile prosthetics, AMS CX and AMS
LGX, which are both part of the AMS 700TM line, and Coloplast Titan®. They specifically studied the axial
load, kink formation, horizontal stiffness, and resistance to three-point flexure testing on human cadavers.
Coloplast Titan® had slightly significantly increased rigidity in horizontal load testing, and increased
rigidity in the longest phallus and the phallus with mild PD, as compared to both the AMS CX and AMS LGX.
However, in the shortest phallus, the AMS CX had better rigidity [10].
Infection Rates
Dhabuwala et al. studied the infection rates between different types of penile implants and different
antibiotic preparations of the devices. Coloplast Titan® penile implants coated with
vancomycin/gentamicin, Coloplast Titan® penile implants coated with rifampin/gentamicin, and
InhibizoneTM-impregnated AMS penile implants were all compared. The implants coated with
vancomycin/gentamicin had an infection rate of 4.4%, the InhibizoneTM-impregnated AMS penile implants
had an infection rate of 1.3%, and none of the implants coated with rifampin/gentamicin developed an
infection. The study did not make any claims about the superiority of certain types of penile implants over
others but did suggest that all Coloplast Titan® penile implants be prepared with rifampin/gentamicin [11].
Comparison of IPP Use in the Treatment of PD
Simultaneous manual penile remodeling and IPP implantation allow for a single procedure that corrects
penile curvature and ED. Chung et al. evaluated clinical outcomes and patient satisfaction in AMS 700 TM
and Coloplast Titan® use in patients with PD and ED. A clinical database review and a prospective
telephone survey were used in a single-center retrospective review. No statistically significant difference in
device survival was found. Both devices also provided similar penile strengthening without the need for
revision surgery [12].
Patient and Partner Satisfaction
Lindeborg et al. evaluated patient satisfaction in 26 patients who underwent Titan® implantation through
an EDITS questionnaire. Eighty-five percent reported being satisfied, 92% would recommend an implant to
someone with a similar medical condition, and 72% believed their partner was satisfied with the implant
[13]. Garrido et al. conducted a retrospective review of Titan® prosthesis performance and patient and
partner satisfaction using a modified EDITS questionnaire. Overall satisfaction was 90% and 84% amongst
patient and partner, respectively, in modified EDITS [14].
Negro et al. directly studied satisfaction after the implantation of the AMS 700 TM LGX. They found the
International Index of Erectile Function (IIEF) scores at six and 12 months were significant for the desired
domain (P = 0.0001) and for overall satisfaction (P = 0.002); however, mean EDITS scores at six and 12
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months were not significantly improved. The greatest improvement in satisfaction was noted after one year
post-surgery, which the authors suggested may be due to both the learning curve as well as the behavioral
and psychosexual adjustment to the IPP [15].
Vitarelli et al. also studied long-term satisfaction with the implantation of AMS 700 TM CX/CXR as measured
by IIEF and the EDITS questionnaire. They found high levels of satisfaction, with 87.7% of patients reporting
satisfaction with implantation with 77.6% prosthesis survival rate at 10 years post-surgery [16].
Otero et al. compared patient and partner satisfaction between the two models. An 11-question, validated,
but modified, questionnaire was used to evaluate patient satisfaction and a non-validated two-item
questionnaire was given to the partner in a retrospective, multicenter, non-randomized study. Two-hundred
forty-eight patients participated and 207 couples completed the questionnaire. Out of the 248 patients, 194
received the 700TM CX and 54 received the Titan®. Overall satisfaction was very high for both prostheses,
and both showed reliability for sexual intercourse. Significant differences, however, were found in three
questions. More patients were satisfied with the 700TM CX (P=0.0001). Only 4% with the 700 TM CX were
dissatisfied with the deflation compared to 24% with the Titan® (P=0.0031). No patient with the Titan® took
longer than six months to optimal management, defined as the use of the device for sexual intercourse with
no help or with the help of his partner [17].
Morgado also compared Coloplast Titan® with AMS 700 TM CX. They assessed 55 patients who received
either one of the prostheses using the EDITS questionnaire. The study found that there was no difference in
satisfaction between patients with Titan® and patients with AMS 700TM CX [18].

Discussion
Summary of Evidence
Biomechanical studies indicate slightly increased axial rigidity in the Titan® model, although this may not
be clinically significant. Otherwise, kink formation, horizontal stiffness, and resistance to three-point
flexure were comparable. Infection rates were slightly higher in implants coated with
vancomycin/gentamicin at 4.4%, compared to InhibizoneTM-impregnated AMS penile implants (1.3%), and
rifampin/gentamicin preparations (0%). In PD, sources indicate that both implants offer good outcomes with
no difference in device outcomes. Overall satisfaction with IPPs is high but differences between the two
devices are inconsistent. Lindeborg et al., 2013, report an 85% satisfaction rate with the Titan® implant and
a 92% recommendation rate. Otero et al., 2017, however, found more patients satisfied with the 700 TM CX.
The results are summarized in Table 3.
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Comparison of
biomechanics

Infection rates

Comparison of IPP
use in the treatment
of PD

Author

Results

Al Ansari
et al. [9]

Slightly increased axial rigidity in Titan, but 700 CX showed a lower dissatisfaction rate.

Wallen et

Coloplast Titan had increased rigidity in horizontal load testing and in the longest phallus and the

al. [10]

phallus with mild PD. In the shortest phallus, the AMS CX had better rigidity.

Dhabuwala
et al. [11]

No claims about the superiority of certain types of penile implants over others but did suggest
that all Coloplast Titan penile implants be prepared with vancomycin/gentamicin.

Chung et

No statistically significant difference in device survival was found. Both devices also provided

al. [12]

similar penile strengthening without the need for revision surgery.

Lindeborg

Patient and partner
satisfaction

85% reported being satisfied with Coloplast Titan, 92% would recommend an implant to

et al. [13]

someone with a similar medical condition, and 72% believed their partner was satisfied with the
implant

Negro et

The greatest improvement in satisfaction was noted after 1-year post-AMS 700 LGX

al. [15]

implantation.

Vitarelli et
al. [16]

87.7% of patients reported satisfaction with AMS 700 implantation with 77.6% prosthesis survival
rate at 10 years post-surgery.

Otero et al.
[17]
Morgado
et al. [18]

More patients were satisfied with the 700CX. Only 4% with the 700 CX were dissatisfied with the
deflation compared to 24% with the Titan. No patient with the Titan took longer than 6 months to
optimal management.
No difference in satisfaction between patients with Titan and patients with AMS 700 CX.

TABLE 3: Summary of results

Limitations
One limitation of our project is the nature of this study. Since this is a literature review, we must rely on
information from other studies where we are unable to account for bias. Additionally, some studies had a
low number of patients, different patient cohorts, different surgical methods, and were predominantly
retrospective. Furthermore, the selection of these studies for review is potentially biased and limited since
we only looked at studies published in English and available through PubMed published within the last 10
years. Furthermore, from our search, we found no international evidence for the superiority of each of these
IPPs.
Additionally, Kramer et al., 2010, compared preoperative expectations to postoperative satisfaction in 21
patients that underwent IPP surgery. Lower preoperative expectations correlated almost linearly to higher
postoperative satisfaction scores (R=-0.489; P=0.0245). This indicates that realistic expectations lead to
higher postoperative satisfaction [19]. Preoperative expectations may play an important role in
postoperative satisfaction, as Kramer et al. suggest. Since the comparability of the preoperative expectations
for these studies is unknown, this could limit our conclusions drawn from the studies. Additionally, the
etiology of ED was unknown in the satisfaction studies, and this could play an important factor in the
satisfaction with IPPs.
Importance and Relevance
The importance of our study is that, to our knowledge, this is the first literature review that synthesizes key
evidence comparing AMS 700TM and Coloplast Titan®. With our study, we look at various components of
these two brands of IPPs in the treatment of ED and access the quality, satisfaction, and outcomes.

Conclusions
Inflatable penile prostheses have been used successfully for ED not responsive to less invasive therapy. Both
the AMS 700TM series and the Coloplast Titan® have three components, infection prevention mechanisms,
and valves that make deflation easier for the user as well as prevent auto-inflation. We found little
substantial difference between the two types of IPPs, with studies showing inconsistent minor superiority of
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one over the other. We recommend surgeons use their own clinical judgment and preference when choosing
the right IPPs to use. Preoperative expectations may play an important role and further research controlling
for this variable is necessary. Lastly, prospective randomized multicenter trials may ultimately determine the
ideal prostheses for specific patients.
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